Inside the stealthy startup that pitched brainless human clones
Summary
MIT Technology Review explores the stealth startup R3 Bio, which aims to develop nonsentient monkey organ sacks and potentially brainless clones for future body replacement. The piece details investors, ethical concerns, and significant technical and regulatory hurdles, while situating the topic within the broader longevity and organ-replacement discourse.